Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Wong

Showing results (171-180 of 228) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2020
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?Nadine Kronfli, Jim Young, Shouao Wang, et al.
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
Ejhaem|August 21, 2023
Immune response to COVID-19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapyKatherine Rankin, Priyanka Hastak, Alexander Wong, et al.
Journal of Viral Hepatitis|August 25, 2018
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individualsSahar Saeed, Erica E M Moodie, Erin Strumpf, et al.
The Journal of Organic Chemistry|August 13, 2005
A convenient preparation of xanthene dyesYoujun Yang, Jorge O Escobedo, Alexander Wong, et al.
The International Journal on Drug Policy|December 30, 2018
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antiviralsRoy Nitulescu, Jim Young, Sahar Saeed, et al.
The International Journal on Drug Policy|February 26, 2022
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in CanadaCharlotte Lanièce Delaunay, Mathieu Maheu-Giroux, Gayatri Marathe, et al.
AIDS (London, England)|April 24, 2018
Medication nonadherence, multitablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppressionCelline C Almeida-Brasil, Erica E M Moodie, Taylor McLinden, et al.
Journal of the International AIDS Society|November 22, 2018
Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in CanadaNadine Kronfli, Roy Nitulescu, Joseph Cox, et al.
AIDS (London, England)|July 27, 2018
Extensive host immune adaptation in a concentrated North American HIV epidemicZabrina L Brumme, Natalie N Kinloch, Stephen Sanche, et al.
Pageof 23

Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2020
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?Nadine Kronfli, Jim Young, Shouao Wang, et al.
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
Ejhaem|August 21, 2023
Immune response to COVID-19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapyKatherine Rankin, Priyanka Hastak, Alexander Wong, et al.
Journal of Viral Hepatitis|August 25, 2018
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individualsSahar Saeed, Erica E M Moodie, Erin Strumpf, et al.
The Journal of Organic Chemistry|August 13, 2005
A convenient preparation of xanthene dyesYoujun Yang, Jorge O Escobedo, Alexander Wong, et al.
The International Journal on Drug Policy|December 30, 2018
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antiviralsRoy Nitulescu, Jim Young, Sahar Saeed, et al.
The International Journal on Drug Policy|February 26, 2022
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in CanadaCharlotte Lanièce Delaunay, Mathieu Maheu-Giroux, Gayatri Marathe, et al.
AIDS (London, England)|April 24, 2018
Medication nonadherence, multitablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppressionCelline C Almeida-Brasil, Erica E M Moodie, Taylor McLinden, et al.
Journal of the International AIDS Society|November 22, 2018
Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in CanadaNadine Kronfli, Roy Nitulescu, Joseph Cox, et al.
AIDS (London, England)|July 27, 2018
Extensive host immune adaptation in a concentrated North American HIV epidemicZabrina L Brumme, Natalie N Kinloch, Stephen Sanche, et al.
Pageof 23